A prime/boost strategy using DNA/fowlpox recombinants expressing the genetically attenuated E6 protein as a putative vaccine against HPV-16-associated cancers

BACKGROUND: Considering the high number of new cases of cervical cancer each year that are caused by human papilloma viruses (HPVs), the development of an effective vaccine for prevention and therapy of HPV-associated cancers, and in particular against the high-risk HPV-16 genotype, remains a priori...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Transl Med
Egile Nagusiak: Bissa, Massimiliano, Illiano, Elena, Pacchioni, Sole, Paolini, Francesca, Zanotto, Carlo, De Giuli Morghen, Carlo, Massa, Silvia, Franconi, Rosella, Radaelli, Antonia, Venuti, Aldo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2015
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4351974/
https://ncbi.nlm.nih.gov/pubmed/25763880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-015-0437-9
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak